生物标志物 生物标志物
Katheryn A Q Cousins1, Rory Boyle2, Colleen Morse3
1Department of Neurology, University of Pennsylvania, Philadelphia, PA, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
这项研究表明,血p-tau217/Aβ42比率是多种人群中阿尔茨海默病的有希望的生物标志物. 它准确地分类疾病状况,并且与其他生物标志物相比,并发病的影响较小.
科学领域:
- 神经学 神经学
- 生物标志物 生物标志物
- 阿尔茨海默氏症疾病研究研究
背景情况:
- 对于阿尔茨海默病 (AD) 的血生物标志物至关重要,但往往受研究环境的限制.
- 这项研究在现实世界中评估了等离子体生物标志物,具有多种疾病的多样化数据集.
研究的目的:
- 评估血生物标志物对阿尔茨海默病 (AD) 病理学的概括性.
- 评估伴随性疾病对不同人群中的血生物标志物水平的影响.
主要方法:
- 利用683名参与者的电子健康记录 (298名黑人/非裔美国人,385名白人).
- 用ICD代码将参与者分为AD痴呆症 (ADD),轻度认知障碍 (MCI),认知障碍 (CI) 和认知正常组.
- 分析了等离子体生物标志物,包括酸化217 (p-tau217) 和β-粉样蛋白1-42/1-40 (Aβ42/Aβ40),评估了与并发症,人口统计和APOE ε4状态的关系.
主要成果:
- 在MCI和ADD中,p-tau217/Aβ42比率升高,并且与年龄,女性性别,APOE ε4和肌素相关.
- 血p-tau217水平显示出类似的关联,而Aβ42/Aβ40随着年龄的增长而下降,ALT,LDL-胆固醇和糖尿病的升高.
- 生物标志物阳性在种族之间没有显著差异. 在p-tau217/Aβ42比率中,未确定的病例率最低 (15%).
结论:
- 血生物标志物,特别是p-tau217/Aβ42比率,显示出对现实世界阿尔茨海默病诊断的潜力.
- 糖尿病和功能受损等并发症会影响血生物标志物水平.
- p-tau217/Aβ42比率可能通过考虑一些并发症效应来提供更强大的衡量标准,尽管肌素仍然是一个混因素.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
746
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
746
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
511
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
511